Neomorph is a biotech company targeting protein degradation to eliminate disease-linked and previously labeled 'undruggable' proteins. The team's expertise in protein degradation and molecular glues allows them to develop heterobifunctional molecules that can degrade proteins using a molecular glue mechanism. Neomorph is collaborating with the Center for Protein Degradation at the Dana Farber Cancer Institute, as well as Novo Nordisk to discover and develop drugs for cardiometabolic and rare diseases. They were founded in 2020 with headquarters located in San Diego, CA.

Neomorph

Senior Scientist, Computational Chemistry

Scientist II, Biomolecular Simulations - Comp Chemistry

Director, DMPK

Sr Scientist, Biology

Up to $1.45 billion on the line in Biogen and Neomorph deal - The Pharma Letter

Neomorph Announces Appointment of Dr. Peter Lebowitz, M.D., Ph.D. to its Board of Directors - PR Newswire

Novo Nordisk Inks $1.46B Deal with Neomorph for Molecular Glue Degraders - Inside Precision Medicine

www.neomorph.com

Celebrating Lisa Strong's remarkable contributions to our team. Keep up the great work!

Neomorph Inks $1.46B Deal with Novo Nordisk - San Diego Business Journal

Life-Sized ALIEN: COVENANT Neomorph Head Statue Is Mortifying - Nerdist

New 'Alien: Covenant' Images Reveal The Creepy 'Neomorph' - SlashFilm

Alien: Covenant Photos Show Bloody Neomorph Carnage - MovieWeb

 Neomorph Inks $1.46B Deal with Novo Nordisk 

Neomorph Announces Multi-Target Collaboration with Novo Nordisk to Discover Novel Molecular Glue Degraders for Cardiometabolic and Rare Diseases - PR Newswire

 Novo Nordisk signs $1.46bn deal to develop molecular glue therapies 

Neomorph, Inc. Announces $109 Million Series A Financing to Advance Proprietary Protein Degradation Platform and Programs - Business Wire

NECA Alien Covenant Creatures - AvP Galaxy


                    Philip Chamberlain Named as Chief Executive Officer of Neomorph
                

How Does Alien: Romulus Connect To Prometheus? - TheGamer

 Novo Nordisk moves into glue degrader sector with Neomorph deal 

UBE2G1 governs the destruction of cereblon neomorphic substrates. Lu G, Weng S, Matyskiela M, Zheng X, Fang W, Wood S, Surka C, Mizukoshi R, Lu CC, Mendy D, Jang IS, Wang K, Marella M, Couto S, Cathers B, Carmichael J, Chamberlain P, Rolfe M. Elife. 2018 Sep 20;7:e40958. doi: 10.7554/eLife.40958. PMID: 30234487; PMCID: PMC6185104.
                    

We're #hiring a new Senior Scientist, Computational Chemistry in San Diego, California. Apply today or share this post with your network.

Biogen, Neomorph partner to advance molecular glue degraders for neurologic conditions - Healio

 Neomorph Lands $1.45B Biogen Pact 

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases - Biogen | Investor Relations

Biogen and Neomorph enter molecular glue degrader deal - Yahoo Finance

Alien: Covenant Neomorph - Origin, Life Cycle & Xenomorph Differences - Screen Rant

Colin Shulver Shares Neomorph & Xenomorph Concept Art from Alien: Covenant - AvP Galaxy

Neomorph vs Xenomorph fight scene was cut from Alien: Covenant - JoBlo.com

Neomorph to Leverage $109 Million Series A Funds Against Undruggable Targets - BioSpace

Creating the Creature Effects of Alien Covenant - AvP Galaxy


              Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases
            

Alien: Covenant Rumors Include Neomorph - Cosmic Book News

We're #hiring a new Scientist II, Biomolecular Simulations - Comp Chemistry in San Diego Metropolitan Area. Apply today or share this post with your network.

We're #hiring a new Assoc. Scientist, Analytical Chemistry in San Diego Metropolitan Area. Apply today or share this post with your network.

 Novo Inks Potential $1.46B Deal to Tap Neomorph’s Molecular Glue Platform 

'Alien: Covenant In Utero' Lets You Experience a Neomorph Birth in VR - Space.com

Alien: Covenant's Neomorph Gets a Funko Vinyl Figure - Screen Rant

 Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases 

Novo Nordisk doles out $1.4B for molecular glue degraders licensing pact - MM+M Online

Novo Nordisk signs $1.46bn deal to develop molecular glue therapies - Pharmaceutical Technology

We're #hiring a new Sr Scientist, Biology in San Diego Metropolitan Area. Apply today or share this post with your network.

Novo Nordisk joins molecular glue club with Neomorph deal - pharmaphorum

Sideshow & CoolProps Life-Size Neomorph Head Replica Available for Pre-Order - AvP Galaxy

Check out the Terrifying new Neomorph in Ridley Scott’s Alien: Covenant - Motion Picture Association

Biogen, Neomorph pact worth $1.45B for molecular glue degraders - BioWorld Online

Novo Nordisk sticks down $1.46B in biobucks for molecular glues with California biotech - Fierce Biotech

 Novo Nordisk sticks down $1.46B in biobucks for molecular glues 

Click here

Alien: Covenant Concept Art Reveals Early Neomorph Design - Screen Rant

Novo Inks Potential $1.46B Deal to Tap Neomorph’s Molecular Glue Platform - BioSpace

Alien: Covenant Photos Reveal Baby Neomorph, Ancient Temple & More - MovieWeb

Neomorph, Inc.

Biogen, Neomorph to collaborate on clinical candidates for Alzheimer's (NASDAQ:BIIB) - Seeking Alpha

 Biogen, Neomorph to collaborate on clinical candidates for Alzheimer's (NASDAQ:BIIB) 

 Novo Nordisk joins molecular glue club with Neomorph deal 

Ridley Scott: Inspiration for Alien: Covenant's Neomorph - IGN

Alien: Covenant Images Feature Neomorphs & Prometheus Connection - Screen Rant

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases - StockTitan

Celebrating Deanna Taylor! Her expertise and commitment are invaluable. 

We are lucky to have you, Deanna!

Click here for Webcast

 Neomorph Pulls $109 Million 

‘Alien: Covenant’: How the VFX Team Engineered Those Terrifying Xenomorph and Neomorph Creatures - IndieWire

New ‘Alien: Covenant’ Photos Reveal the Neomorph in All Its Gruesome Glory - ScreenCrush

We're #hiring a new Scientist II, Biology in San Diego Metropolitan Area. Apply today or share this post with your network.

We're #hiring a new Director, DMPK in San Diego, California. Apply today or share this post with your network.

There Was Going to Be a Xenomorph vs Neomorph Fight in ‘Alien: Covenant’ - Bloody Disgusting

https://neomorph.com/index.html#news

 Biogen, Neomorph pact worth $1.45B for molecular glue degraders 

 Biogen, Neomorph announces multi-target research collaboration 

Alien: 5 Reasons Why Neomorphs Are Deadlier Than Xenomorphs (& 5 Why They're Not) - Screen Rant

My Life as a Teenaged Neomorph: Experiencing ‘Alien Covenant: In Utero’ - The Knoxville Mercury

Biogen buys in to molecular glues with Neomorph deal worth up to $1.45B - Fierce Biotech


                    Neomorph, Inc. Announces $109 Million Series A Financing to Advance Proprietary Protein Degradation Platform and Programs
                

Biogen forges $1.4B+ deal with Neomorph around molecular glue degraders - FirstWord Pharma

 Neomorph Announces Multi-Target Collaboration with Novo Nordisk to Discover Novel Molecular Glue Degraders for ... 

‘Alien: Covenant’ VFX Team Hatches New Neomorph, Xenomorphs - Hollywood Reporter

Biogen signs molecular glue deal, raises yearly projections - Endpoints News

Neomorph Lands $1.45B Biogen Pact - San Diego Business Journal

Novo Nordisk and Neomorph enter molecular glue degrader partnership worth over $1.4bn - PMLiVE

Neomorph Vs. Xenomorph Fight Almost Happened in Alien: Covenant - MovieWeb

Neomorph, Inc. Announces Appointment of Chief Financial Officer - Business Wire

‘Alien: Covenant’: How the VFX Team Engineered Those Terrifying Xenomorph and Neomorph Creatures - Yahoo Entertainment

 Neomorph, Inc. Announces Appointment of Chief Financial Officer 


                    Neomorph, Inc. to Participate in Upcoming Guggenheim Healthcare Talks – Targeted Protein Degradation Day
                

Neomorph

Business:

About: